Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab”

Sun Hyun Bae; Hee Chul Park

doi:10.17998/jlc.2023.08.18

Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab”

Sun Hyun Bae
, Hee Chul Park

Department of Radiation Oncology

Soonchunhyang University

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	402-404
Number of pages	3
Journal	Journal of Liver Cancer
Volume	23
Issue number	2
DOIs	https://doi.org/10.17998/jlc.2023.08.18
State	Published - Sep 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Atezolizumab
Bevacizumab
Carcinoma, hepatocellular
Radiotherapy

Access to Document

10.17998/jlc.2023.08.18

Cite this

@article{f1dc756d310b4ba7a51b9159ac1e5a69,

title = "Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab”",

keywords = "Atezolizumab, Bevacizumab, Carcinoma, hepatocellular, Radiotherapy",

author = "Bae, \{Sun Hyun\} and Park, \{Hee Chul\}",

year = "2023",

month = sep,

doi = "10.17998/jlc.2023.08.18",

language = "English",

volume = "23",

pages = "402--404",

journal = "Journal of Liver Cancer",

issn = "2288-8128",

publisher = "Korean Liver Cancer Association",

number = "2",

}

TY - JOUR

T1 - Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab”

AU - Bae, Sun Hyun

AU - Park, Hee Chul

PY - 2023/9

Y1 - 2023/9

KW - Atezolizumab

KW - Bevacizumab

KW - Carcinoma, hepatocellular

KW - Radiotherapy

UR - https://www.scopus.com/pages/publications/85210859726

U2 - 10.17998/jlc.2023.08.18

DO - 10.17998/jlc.2023.08.18

M3 - Article

AN - SCOPUS:85210859726

SN - 2288-8128

VL - 23

SP - 402

EP - 404

JO - Journal of Liver Cancer

JF - Journal of Liver Cancer

IS - 2

ER -

Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab”

UN SDGs

Keywords

Access to Document

Other files and links

Cite this